Journal rankings · indicator year 2021
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2021
Cancer Research journal rankings 2021
27 ranked journals · Subfield in Biochemistry, Genetics and Molecular Biology
Cancer Research has 27 ranked journals in 2021. The median OJR fell 0.08 on 2020 to 0.68, below the world average of 1.00; Q1 starts at OJR 1.06. The top three are Biomarker Insights, Non-Coding RNA, and Mutation Research/Reviews in Mutation Research.
Ranks and citation indicators: 2021. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2018–2020, the window the 2021 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Biochemistry, Genetics and Molecular Biology (14)
27 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2020. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2018–2020, the window the 2021 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2018–2020 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2012 to 2021. | Compare |
|---|---|---|---|---|---|---|---|
1Biomarker InsightsOASAGE Publishing · United Kingdom | 1.82Q1 | 4.00 3.05 down from 2020 | 53 | 100% | $2,650 | ||
2Non-Coding RNAOAMultidisciplinary Digital Publishing Institute · Switzerland | 1.51Q1 | 7.82 0.73 down from 2020 | 145 | 100% | $2,172 | ||
3Mutation Research/Reviews in Mutation ResearchElsevier BV · Netherlands | 1.37Q1 | 6.33 1.08 down from 2020 | 97 | 46% | $4,160 | ||
4Cancer & MetabolismOABioMed Central · United Kingdom | 1.29Q1 | 5.85 0.05 down from 2020 | 60 | 100% | $3,190 | ||
5Non-coding RNA ResearchOAElsevier BV · China | 1.26Q1 | 5.63 1.27 down from 2020 | 78 | 100% | $1,100 | ||
6Journal of Molecular DiagnosticsElsevier BV · United States | 1.14Q1 | 4.78 0.66 up from 2020 | 362 | 98% | $3,000 | ||
7Breast Cancer Research and TreatmentSpringer Science+Business Media · Netherlands | 1.06Q1 | 4.32 0.37 down from 2020 | 1,338 | 47% | $4,190 | ||
8Breast Cancer Basic and Clinical ResearchOASAGE Publishing · United States | 0.84Q2 | 2.69 0.69 down from 2020 | 79 | 100% | $2,650 | ||
9Journal of Breast CancerOASouth Korea | 0.79Q2 | 3.34 0.35 down from 2020 | 182 | 100% | $500 | ||
10Breast CancerSpringer Science+Business Media · Japan | 0.79Q2 | 3.29 0.06 down from 2020 | 349 | 40% | $3,890 | ||
11Clinical Breast CancerElsevier BV · United States | 0.78Q2 | 3.16 0.10 up from 2020 | 501 | 33% | $3,470 | ||
12Pathology - Research and PracticeElsevier BV · Germany | 0.74Q2 | 3.26 0.08 up from 2020 | 1,167 | 22% | $2,780 | ||
13Environmental and Molecular MutagenesisWiley · United States | 0.70Q2 | 3.31 0.10 up from 2020 | 203 | 53% | $3,750 | ||
14Mutation Research/Genetic Toxicology and Environmental MutagenesisElsevier BV · Netherlands | 0.68Q2 | 2.89 0.21 down from 2020 | 323 | 26% | $3,350 | ||
15The BreastOAElsevier BV · United Kingdom | 0.66Q3 | 2.52 0.20 up from 2020 | 726 | 100% | $3,200 | ||
16BiomedicineOAEDP Sciences · Netherlands | 0.65Q3 | 1.52 0.93 down from 2020 | 85 | 100% | — | ||
17MutagenesisOxford University Press · United Kingdom | 0.65Q3 | 2.90 0.20 up from 2020 | 127 | 51% | $4,170 | ||
18Genes and EnvironmentOABioMed Central · Japan | 0.57Q3 | 2.87 0.68 up from 2020 | 83 | 100% | $2,590 | ||
19MicroRNABentham Science Publishers · Netherlands | 0.55Q3 | 1.59 1.20 down from 2020 | 103 | 14% | — | ||
20Critical Reviews in Eukaryotic Gene ExpressionBegell House · United States | 0.50Q3 | 1.42 0.56 down from 2020 | 134 | 18% | — | ||
21British Journal of Biomedical ScienceOATaylor & Francis · United Kingdom | 0.42Q3 | 1.72 0.95 down from 2020 | 127 | 10% | $2,506 | ||
22The Breast JournalOAWiley · United Kingdom | 0.40Q4 | 1.48 0.12 up from 2020 | 872 | 53% | $2,350 | ||
23Breast DiseaseIOS Press · Netherlands | 0.39Q4 | 1.89 0.81 up from 2020 | 52 | 3% | — | ||
24Non-coding RNA InvestigationOAAME Publishing Company · Hong Kong SAR China | 0.11Q4 | 0.58 0.02 down from 2020 | 73 | 100% | — | ||
25Journal of Biomaterials and Tissue EngineeringAmerican Scientific Publishers · United States | 0.04Q4 | 0.15 0.02 down from 2020 | 696 | 1% | — | ||
26International Journal of Human GeneticsOAKamla Raj Enterprises · India | 0.04Q4 | 0.14 0.02 up from 2020 | 77 | 100% | — | ||
27Journal of Cancer Treatment and ResearchOAScience Publishing Group · United States | 0.00Q4 | 0.00 0.26 down from 2020 | 31 | 100% | — |
Subfields of Biochemistry, Genetics and Molecular Biology, with Cancer Research highlighted.
- Molecular Biology1,136
- Genetics120
- Cancer Research27
- Cell Biology27
- Molecular Medicine9
- Biophysics8
- Clinical Biochemistry4
- Biochemistry2
- Endocrinology2
- Structural Biology2
- Developmental Biology1
- Physiology1
- Aging0
- Biotechnology0
Journals
Citations made in 2021. Corpus-wide, 87.7% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
17 additional Cancer Research journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2018–2020, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2021. Publication window: 2018–2020. How these summaries are calculated
- Ranked journals
- 27
- Window papers (baseline)
- 61,698 +17.9% from indicator year 2018
- Median OJR
- 0.679 -15.5% from indicator year 2018
- Rising journals (2025)
- 2
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2018–2020 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 12 | 14 | 15 | 16 | 16 | 19 | 20 | 21 | 21 | 22 | 21 | 20 | 21 | 24 | 23 | 25 | 26 | 27 | 28 | 27 | 29 | 27 | 27 | 26 | 27 | 29 | |
| Window papers (baseline) | 14,247 | 15,312 | 16,615 | 17,745 | 18,774 | 20,529 | 22,718 | 25,259 | 27,535 | 30,135 | 32,914 | 35,940 | 38,839 | 41,424 | 44,722 | 47,640 | 50,019 | 51,182 | 52,328 | 54,530 | 57,576 | 61,698 | 64,508 | 64,646 | 60,806 | 56,699 | |
| Median OJR | 0.49 | 0.50 | 0.46 | 0.60 | 0.71 | 0.58 | 0.67 | 0.680 | 0.768 | 0.8139 | 0.72 | 0.798 | 0.93 | 0.92 | 0.88 | 0.84 | 0.7969 | 0.8143 | 0.804 | 0.82 | 0.76 | 0.679 | 0.70 | 0.79 | 0.770 | 0.7966 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.